Besides the commonly used panendothelial markers such as CD31, CD34, Factor VIII, endoglin (CD105) has been proposed as a marker of tumor angiogenesis since the endoglin antibody binds preferentially to the activated endothelial cells that participate neovascularization [11, 12]. This evidence concerns the gene PECAM1 and neoplasm.